US Stock Market Movement: Genmab Surges on October 5 Due to AbbVie Collaboration, EPKINLY Phase III Results, and Rina-S
Bitget异动解读2026/10/05 18:55Genmab Surges on October 5th: Analysis
Keywords: AbbVie collaboration, EPKINLY Phase III, Rina-S
1. On October 6th, Genmab and AbbVie announced that the Phase III trial of EPKINLY combined with R-CHOP for the treatment of newly diagnosed diffuse large B-cell lymphoma showed a statistically significant improvement in progression-free survival, with a 51% reduction in the risk of disease progression or death.
2. On October 3rd, Genmab released data from the RAINFOL-01 trial of Rina-S for the treatment of platinum-resistant ovarian cancer: among 109 patients, the confirmed objective response rate was 45.9%, including 5 complete responses, with a median duration of response of 12.1 months and median progression-free survival of 9.5 months. Antitumor activity was observed regardless of FRα expression level and prior treatment with mirvetuximab.
(Disclaimer: This content is generated by AI technology based on publicly available information and is for reference only. It does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
US stock fluctuation: Enliven plunged on October 6th due to high-level correction and profit-taking.
Central 1 expects the Bank of Canada to raise interest rates only twice in this round, and to start in early next year.
Central 1 Credit Union in Canada anticipates that the Bank of Canada may only raise interest rates twice during the current tightening cycle, with the first hike expected to occur early next year, which is significantly less aggressive than current market pricing suggests. Central 1 economist Bryan Yu stated that Canada is currently experiencing a period of high uncertainty, with the economic outlook rapidly evolving. The sharp rise in U.S. and Canadian bond yields, the impact of tariffs, and drastic fluctuations in oil prices have all increased the difficulty of policy decisions. Yu pointed out that Canada’s core inflation remains close to 2%, and due to trade uncertainties, economic growth may slow by the end of 2026. Meanwhile, elevated bond yields could also suppress the recovery of the real estate market, thereby limiting both the necessity and room for the Bank of Canada to further tighten monetary policy.
Crypto prices
More
